Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress Mar 16, 2026 4:05 PM Eastern Daylight Time Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress Share Atara delivers significant operational efficiencies and extends cash runway through year-end 2026 A Type A meeting has been scheduled between Pierre Fabre Pharmaceuticals and the FDA THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Atara Biotherapeutics ...